|
|
|
Manel Pladevall, MD, MSc
Investigator
Contact Information:
Email: mpladev1@hfhs.org
Phone: (313) 874-5454
Fax: (313) 874-7137
Recent Publications:
Heisler
M, Hogan MM, Hofer TP, Schmittdiel JA,
Pladevall M,
Kerr EA. When More Is Not Better: Treatment Intensification
Among Hypertensive Patients With Poor Medication Adherence.
Circulation 2008 June 3;117(22):2884-92
Paris
J, Peterson EL, Wells K,
Pladevall
M,
Burchard EG, Choudhry S,
Lanfear DE,
Williams LK.
Relationship between recent short-acting β-agonist use and
subsequent asthma exacerbations. Ann Allergy Asthma Immunol
2008 Nov;101(5):482-7.
Wells
K,
Pladevall M,
Peterson EL,
Campbell J, Wang M, Lanfear DE, Williams LK.
Race-ethnic Differences in Factors Associated with Inhaled
Steroid Adherence Among Adult Asthmatics.
Am J Respir Crit Care Med 2008 Dec
15;178(12):1194-201. Epub 2008 Oct 10.
Biography:
Dr. Manel Pladevall-Vila received an MD in 1982 form the
Autonomous Barcelona University in Spain. He did his residency
in Internal Medicine and fellowship in Hypertension at Vic
General Hospital (Barcelona, Spain). He received and MS degree
in epidemiology from the University of Texas in 1992. Dr. Manel
Pladevall-Vila serves since February 2002 as Research Scientist
for the Center for Health Services Research at the Henry Ford
Health System in Detroit, MI. Dr. Pladevall's main research
interests are in the cardiovascular area. He has been the
principal investigator of two epidemiological studies on the
epidemiology of the metabolic Syndrome, funded by the Spanish
government. While in Spain, he participated in several clinical
trials in the cardiovascular area and was an active member of
the Spanish Cochrane Collaboration. He currently is the
principal investigator of another Spanish funded study, a
multi-center cluster randomized trail of an intervention to
improve adherence to blood pressure lowering drugs in patients
at high cardiovascular risk. Among his latest areas of research
are the usefulness of claims data to measure adherence and the
association between levels of adherence and clinical outcomes.
|